Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 26, 2003
Issued Date -
N/A
app pub date -
Jan 26, 2001
filing date -
Jul 30, 1998
priority date (Note) -
Expired
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
Alkanoyl L-carnitines of the formula: ##STR1## where R is hydrogen or a C.sub.2-8 alkanoyl group and X.sup.- is an anion of a pharmaceutically acceptable salt, are used in conjunction with anticancer agents such as taxol or bleomycin to improve the therapeutic index and reduce side effects typical of anticancer chemotherapy.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
PLASMION CORPORATION | 50 HARRISON STREET HOBOKEN NJ 07030 |
International Classification(s)
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Cavazza, Claudio | Rome, IT | 123 | 1453 |
# of filed Patents : 123 Total Citations : 1453 | |||
Pisano, Claudio | Aprilia, IT | 60 | 146 |
# of filed Patents : 60 Total Citations : 146 | |||
Vesci, Loredana | Rome, IT | 29 | 82 |
# of filed Patents : 29 Total Citations : 82 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 7 Citation Count
- A61K Class
- 10.18 % this patent is cited more than
- 22 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Sep 21, 2015 | STCH | INFORMATION ON STATUS: PATENT DISCONTINUATION | free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
Aug 26, 2015 | FP | LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE | Effective Date: Aug 26, 2015 |
Aug 26, 2015 | LAPS | LAPSE FOR FAILURE TO PAY MAINTENANCE FEES | |
Apr 03, 2015 | REMI | MAINTENANCE FEE REMINDER MAILED | |
Feb 28, 2011 | FPAY | FEE PAYMENT | year of fee payment: 8 |
Feb 26, 2007 | FPAY | FEE PAYMENT | year of fee payment: 4 |
Aug 26, 2003 | I | Issuance | |
Nov 22, 2001 | P | Published | |
Jul 09, 2001 | AS | ASSIGNMENT | free format text: MERGER;ASSIGNOR:SKION CORPORATION;REEL/FRAME:013789/0944 Owner name: PLASMION CORPORATION, NEW JERSEY Effective Date: Jul 09, 2001 |
Jan 26, 2001 | F | Filing | |
Jan 22, 2001 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CAVAZZA, CLAUDIO;PISANO, CLAUDIO;VESCI, LOREDANA;REEL/FRAME:011481/0225 Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A., Effective Date: Jan 22, 2001 |
Jul 30, 1998 | PD | Priority Date |

Matter Detail

Renewals Detail
